•   
  •   
  •   

World Kremlin dismisses vaccine disinformation campaign accusations as 'circus'

18:35  18 october  2020
18:35  18 october  2020 Source:   cnn.com

171 countries are teaming up for a Covid-19 vaccine. But not the US.

  171 countries are teaming up for a Covid-19 vaccine. But not the US. Vaccine nationalism is real. But so is vaccine multilateralism.Today, there are 40 vaccine candidates for the coronavirus being studied in humans — including nine in the final phase of testing.

Kremlin spokesperson Dmitry Peskov dismissed the reaction of the UK Foreign Secretary Dominic Raab to the Times report saying that Russia is engaging in a disinformation campaign to discredit the Oxford University coronavirus vaccine in an effort to promote its own vaccine Sputnik V

Kremlin spokesman Dmitry Peskov told reporters Friday in the Russian capital that the Peskov dismissed allegations Moscow has launched a vaccine disinformation campaign . "Commenting on accusations against Russia has become a sort of circus at this point," Peskov told reporters.

Vladimir Putin sitting at a desk: Russian President Vladimir Putin announced the vaccine on a video conference call with government officials. © Alexey Nikolsky/Sputnik/AFP via Getty Images Russian President Vladimir Putin announced the vaccine on a video conference call with government officials.

Kremlin spokesperson Dmitry Peskov dismissed the reaction of the UK Foreign Secretary Dominic Raab to the Times report saying that Russia is engaging in a disinformation campaign to discredit the Oxford University coronavirus vaccine in an effort to promote its own vaccine Sputnik V, developed by the Gamaleya Institute.

"Commenting on the accusations against Russia is getting more and more circus-like," Peskov said in a conference call with reporters Friday. "Russia is not misinforming anyone, Russia proudly talks about its successes and Russia shares its successes regarding the first ever registered [coronavirus] vaccine in the world."

Q&A: How far can Trump go in pushing a COVID-19 vaccine that isn't ready?

  Q&A: How far can Trump go in pushing a COVID-19 vaccine that isn't ready? The Trump administration seems to be going to great lengths to get a COVID-19 vaccine produced by election day. How much can they get away with?President Trump has made clear that his top priority is speed. For a time, his administration rejected the Food & Drug Administration's proposed criteria for assessing vaccine candidates — criteria which make it all but impossible to have a vaccine available by election day.

Russian state media and pro- Kremlin outlets are waging a disinformation campaign about the coronavirus pandemic to sow "panic and fear" in the West, EU officials have warned in a report seen by CNN.

The Kremlin on Thursday described accusations by Britain that Russia, along with China and Iran, was looking to exploit "We categorically disagree with such statements," said Kremlin spokesman Dmitry Peskov. "As far as disinformation is concerned, we consider such accusations absurd."

The Times published a report on Friday outlining a supposed Russian disinformation campaign "designed to undermine and spread fear about the Oxford University coronavirus vaccine." The campaign involves spreading memes and videos suggesting the vaccine, manufactured by a pharmaceutical company AstraZeneca is "a monkey vaccine" that could turn people into monkeys because it uses a chimpanzee virus as a vector, according to the newspaper.

"We know that Russia has got a track record in this area. Previously we've commented and called them out on it," Raab said in an interview with Sky News.

"But anyone trying to basically sabotage the efforts of those trying to develop a vaccine I think are deeply reprehensible. It's unacceptable and unjustified in any circumstances."

China Covid-19 vaccine: Inside the company at the forefront of China's push to develop a coronavirus vaccine

  China Covid-19 vaccine: Inside the company at the forefront of China's push to develop a coronavirus vaccine Inside the white, sterile walls of a new building on the southern outskirts of Beijing, two employees donning masks and rubber gloves are busy pipetting a clear, colorless liquid into rows of small vials. © NICOLAS ASFOURI/AFP/AFP via Getty Images In this picture taken on April 29, 2020, an engineer shows an experimental vaccine for the COVID-19 coronavirus that was tested at the Quality Control Laboratory at the Sinovac Biotech facilities in Beijing.

MOSCOW (Reuters) - The Kremlin on Thursday described accusations by Britain that Russia, along with China and Iran, was looking to exploit opportunities created by the coronavirus, as "absurd". "We categorically disagree with such statements," said Kremlin spokesman Dmitry Peskov.

The race to create—and then sell—a coronavirus vaccine is not just the number one priority in Some of the content produced for the alleged campaign , is, in the words of Manveen Rana, one of the The reported disinformation campaign from Russia is a reminder that will not always be a clean contest.

The Times said a "whistleblower" "involved in the campaign" passed on the images to the paper out of concern about potential damage to the public health efforts. The newspaper notes it is not clear whether the campaign was directly authorized by the Kremlin but added "there is evidence that some Russian officials were involved in its organisation and dissemination."

"Misinformation is a clear risk to public health. This is especially true during the current pandemic which continues to claim tens of thousands of lives, significantly disrupt the way we live and damage the economy," Pascal Soriot, CEO at AstraZeneca, said in a statement.

"I urge everyone to use reliable sources of information, to trust regulatory agencies and to remember the enormous benefit vaccines and medicines continue to bring to humanity."

Disinformation is "reckless and contemptible behaviour that could lead to real damage to people's health", said a source in Whitehall, the area in central London where key UK ministries are based. "This sort of lie fundamentally harms all of us around the world and we need to be alert to identify and counter this kind of activity to support the provision of factual information for all people about Covid-19 and vaccines."

COVID Vaccine Update as Johnson & Johnson Trial Suffers Setback, Sanofi Aims for Mid-2021 Rollout

  COVID Vaccine Update as Johnson & Johnson Trial Suffers Setback, Sanofi Aims for Mid-2021 Rollout There may be "up to 100 million doses" of a COVID-19 vaccine available by the end of the year, U.S. Secretary of Health and Human Services Alex Azar stated last week.On Monday, U.S.-based Johnson & Johnson announced a pause on all of its COVID-19 vaccine candidate clinical trials due to an "unexplained illness" in one of its study participants.

Pro- Kremlin information operations employ six complementary tactics to achieve that goal, and the ongoing disinformation campaign on COVID-19 is On several occasions, in the aftermath of a terror attack in Europe or the United States, pro- Kremlin outlets spread accusations that the attack was a

Russia has rejected accusations it is spreading disinformation about the coronavirus pandemic in the US. He continued: “So in this case if anyone talks about some kind of disinformation , it is some kind of persistent phobia, and there is no need to blame objective and quality work of the media.”

When asked to comment on the article, the Kremlin spokesperson in turn accused the UK of spreading disinformation about the Russian vaccine suggesting it's a testament to the unfair competition in the vaccine race.

"Russia already has documents of intention to sell or jointly produce this vaccine in a number of countries, and of course in these countries Russia is not shying away from informing [the public] about the advantages of our vaccine," Peskov said. "A number of [producers] who could be called competitions, they are the ones engaging in disinformation, the disinformation agents are sitting in the UK, among other places."

According to the Times, the campaign was aimed at "countries such as India and Brazil where Russia was trying to market its own vaccine" as well as Western countries that are developing their own vaccines. To date, Russian sovereign wealth fund (or the RDIF), which sponsors the vaccine, said it reached deals to supply Sputnik V to India and Brazil, among others.


Video: Why she is volunteering to get infected with Covid-19 (CNN)

Europe Is Still Wide Open to Russian Information-Warfare Attacks

  Europe Is Still Wide Open to Russian Information-Warfare Attacks Since news first broke that Russian opposition leader Alexey Navalny had been poisoned with a nerve agent, some of the most popular coverage in Germany has come from Kremlin-funded outlets questioning Berlin’s efforts to blame Moscow for the attack. RT Deutsch’s stories denouncing the accusations as shrill and hypocritical ranked among the top 10 most shared sources on German-language social media on the subject, registering more engagement than official government statements or coverage in mainstream outlets like Welt, Bild and broadcaster ZDF, according to analysis by the European Union covering the period since the August atta

The Kremlin has dismissed accusations that President Vladimir Putin sanctioned the poisoning of critic Alexei Navalny. Spokesman Dmitry Peskov said the allegations were untrue and could not be taken seriously. Doctors in Germany, where Mr Navalny is being treated

Russian opposition critic remains in a coma in hospital in Berlin.

RDIF said it condemns social media attacks against AstraZeneca vaccine.

"We condemn the social media posts aimed to denigrate AstraZeneca vaccine described by The Times today. We believe any attempts to smear any vaccine are wrong including those against Gamaleya's Sputnik V vaccine," Kirill Dmitriev, the CEO of the RDIF, told CNN in a statement Friday. "All vaccines should, of course, be subject to the most rigorous scientific investigation."

However, the "monkey vaccine" narrative has been voiced by Russian officials and the state media before.

On September 9, following the news of a pause in AstraZeneca's global trials due to an unexplained illness, Dmitry Peskov said the British vaccine is less safe as it is a "monkey vaccine" while the Russian development is a "human vaccine" and believed to be "much more reliable" by the Russian scientists.

Crude images depicting monkeys with captions such as "Monkey vaccine is fine" and similar memes have appeared on Russian state media two days after AstraZeneca announced the pause. On September 10, Russian state-news agency RIA Novosti published an editorial piece titled "Why the West is losing the vaccine race: Russia has been exposed," which contained four caricatures on the monkey vaccine with English captions.

States prepare for their own vaccine safety reviews amid worries about Trump’s influence on the FDA

  States prepare for their own vaccine safety reviews amid worries about Trump’s influence on the FDA It's not yet clear whether the states would seek to block distribution of a vaccine they deem unsafe or ineffective, or just broadcast those concerns far and wide.New York, California, Michigan, West Virginia, Washington D.C. and potentially a handful of others are in the early stages of creating independent panels to review vaccine data as it becomes available – although it’s not yet clear whether all these states would seek to block distribution of a vaccine they deem unsafe or ineffective, or just to broadcast those concerns.

AstraZeneca has since resumed the trials in the UK. In the US, the FDA is considering whether to allow AstraZeneca to restart its trial after a participant became ill. At issue is whether the illness was a fluke, or if it may have been related to the vaccine.

The head of the Russian Direct Investment Fund, which sponsors the development of Sputnik V, said in September the company is "delighted" to see that the AstraZeneca trials are moving forward but called the approach "unacceptable" due to "excessive reliance upon new unverified technologies," including the use of a monkey adenovirus vector or mRNA technology.

In July, however, the RDIF announced that one of its portfolio companies, drug maker R-Pharm, reached a deal with AstraZeneca to produce the Oxford vaccine in Russia. The announcement came after warnings that Russia-linked actors are attempting to hack UK, US and Canada-based research centers in order to gather intelligence on the vaccine production. Russia denied any involvement.

The head of the RDIF Kirill Dmitriev told Reuters at the time Moscow did not need to steal any secrets as it already had a deal with AstraZeneca to manufacture the potential British vaccine in Russia.

"The transfer of the cell line and the adenovirus vector to Russia has been carried out; it is planned to produce the antigen here and produce the finished doses," R-Pharm said in a July statement. "At the same time, Russia will be one of the hubs for the production and supply of the vaccine to international markets."

You Can Now Get a COVID-19 Vaccine in China. That Might Not Be a Good Thing

  You Can Now Get a COVID-19 Vaccine in China. That Might Not Be a Good Thing In China, an unofficial vaccine rollout is gathering pace despite the warnings of international public health experts . In September, state-owned SinoPharm revealed that hundreds of thousands of Chinese had already taken its experimental COVID-19 vaccines as part of a state initiative to protect frontline health workers and officials traveling to high-risk nations. In the eastern manufacturing hub of Yiwu this week, hundreds of people queued for a $60 dose of the CoronaVac vaccine made by private firm SinoVac.Read more: ‘We Will Share Our Vaccine with the World.

When asked Friday to comment whether AstraZeneca's pause in trials and technology threatens the deal with a Russian producer, Dmitriev said: "One of our portfolio companies is manufacturing the AstraZeneca vaccine. We believe that both human adenoviral vector approach that Sputnik V is using, and chimpanzee adenoviral vector approach used by AstraZeneca are both very promising approaches based on solid scientific basis."

Gamaleya is using adenoviruses in their Covid-19 vaccines; this is the same approach used in the vaccine developed by the University of Oxford and AstraZeneca. The adenovirus delivers genetic material for the spike protein that sits atop the virus that causes Covid-19, and that genetic material is designed to generate an immune response to the virus.

Adenoviruses can cause a variety of symptoms, including the common cold. The researchers manipulate the virus so it will not replicate and cause illness.

The Gamaleya vaccine is given in two doses, and each dose uses a different adenovirus vector.

Russia registered its first coronavirus vaccine Sputnik V in August after testing it on 76 volunteers and ahead of large-scale Phase 3 trials. The announcement came to much fanfare from Russian state media but drew widespread skepticism from the international community concerning its safety and the notion the approval could've been rushed by political goals. Sputnik V is now in its stage 3 trial which so far involved 13,000 people and seeking to enroll up to 40,000, according to Russian officials.

AstraZeneca began large-scale phase 3 human clinical trials in August seeking to enroll up to 30,000. Such trials are the last step before a vaccine maker seeks approval from regulators.

Another vaccine EpiVacCorona developed by a former biochemical weapons lab Vector, was registered in Russia this week before going through Phase 3 trials. The third potential Russian vaccine, from the Chumakov Institute, began Phase I trials last week.

The FDA and CDC Promised Transparency in the Vaccine Approval Process. Here's How Congress Can Hold Them to It .
Senators Maggie Hassan and Lisa Murkowski introduced the SAVE Act to ensure that the CDC and FDA follow through with the transparency they committed to around vaccine approval process.While we all hope to get potential vaccines reviewed, produced and distributed as quickly as possible, we can’t sacrifice safety and efficacy for speed. It is also critically important that the public has confidence in the federal government’s vaccine review process, which includes assurances that the Food and Drug Administration (FDA) has followed the necessary protocols to ensure vaccine safety and effectiveness.

usr: 8
This is interesting!